Brian Bohnenkamp is an associate in King & Spalding’s Washington, D.C., office and a member of the FDA & Life Sciences Practice Group. He has assessed a variety of regulatory compliance issues for manufacturers of drugs and medical devices. Specifically, he has assisted in advising companies on state law compliance issues, development and implementation of comprehensive compliance programs, fraud and abuse issues, and advertising and promotion practices. Mr. Bohnenkamp provides counsel to the Ad Hoc State Law Compliance Group (a coalition of pharmaceutical, biotechnology, and medical device manufacturers) on a variety of laws and regulations, including state marketing code of conduct laws, gift prohibition laws, marketing costs disclosure laws, and prescriber data privacy laws, as well as the federal Physician Payment Sunshine provisions.
Prior to joining King & Spalding, Mr. Bohnenkamp held several health care administrative and legal residencies, where he assisted with analysis of medical staff and hospital bylaws, development of corporate compliance plans, issues related to hospital joint ventures, and various other legal and operational issues.
In a joint-degree program, Mr. Bohnenkamp received his J.D., magna cum laude, from Saint Louis University School of Law, and his M.H.A., highest distinction, from Saint Louis University School of Public Health. He also served two years as a Lead Editor of the American Health Lawyers Association Journal of Health Law and received a Health Law Certificate. Mr. Bohnenkamp graduated from Indiana University with a B.A. in psychology, highest distinction, as a member of Phi Beta Kappa.
Recent Publications
Speeches
- “Here Comes the Sun[shine]: Preparing for the Physician Payment Sunshine Act,” Pharmaceutical & Medical Device Sales & Marketing Compliance Conference, Chicago, IL (July 18, 2011)
- “Understanding State Marketing Laws and Impending Federal Sunshine Requirements,” Medical Device & Diagnostics Sales Training & Development Conference, Dallas, TX (March 1, 2011)
- “Implementing a Comprehensive Aggregate Spend and Disclosure Solution to Ensure Compliance with US and International Regulations,” Live Webcast (November 4, 2010)
- “Understanding New State Pharmaceutical Marketing Laws and Their Effect on Your Overall Sales Performance,” Pharmaceutical Sales Training & Development Conference, Chicago, IL (September 14, 2010)
- “What’s Next for the States: Pushing the Envelope on Disclosure and Gift Bans,” 2010 National Disclosure Summit, Washington, D.C. (March 4, 2010)
- “The Changing Nature of Life Sciences/Provider/Professional Relationships,” Illinois Association of Healthcare Attorneys 27th Annual Health Law Symposium, Chicago, IL (October 21, 2009)
- “State Data Mining Restrictions - What’s Next?,” CBI and Pharmaceutical Executive’s 2nd Annual Leadership Summit on Evolving the Pharma Sales Model, Philadelphia, PA (September 24, 2009)
- “How State Laws Affect Your Company,” 2009 Regulatory Affairs Professionals Society Annual Conference, Philadelphia, PA (September 12, 2009)
Articles
- Brian Bohnenkamp, Seth Lundy & Ami Patel, “States Want Healthier Professional Relationships: More State Legislatures are Tightening Restrictions on the Promotional Activities of Medical Device Companies,” MX Medtech Executive, April 2010
- Brian Bohnenkamp & Christina Markus, “Evolving Expectations for Transparency of Industry-Healthcare Provider Relationships,” American Health Lawyers Association, Life Sciences Newsletter, Volume 3, Issue 2, Oct. 2009
- Brian Bohnenkamp & Nikki Reeves, “How The New Massachusetts Marketing Code Of Conduct And Disclosure Requirements Will Impact Medical Device Manufacturers,” American Health Lawyers Association, 7 Health Lawyers Weekly 14, Apr. 10, 2009
